MEFV, TNFRSFIA and CARD15 mutation analysis in Behçet's disease

Clinical and Experimental Rheumatology

Volumn 29, Issue 4 SUPPL. 67, 2011, Pages

  Baruch, Y ^a   Dagan, E ^b,c   Rosner, I ^d,e   Fiorilli, M ^a   Gershoni Baruch, R ^b,e   Rozenbaum, M ^d,e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Rambam   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

^d BNAI ZION MEDICAL CENTER   (Israel)

^e TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Beh et's disease; Crohn's disease; FMF; TRAPS

Indexed keywords

ADOLESCENT; ADULT; ARAB; ARTICLE; BEHCET DISEASE; CARD15 GENE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE CARRIER; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MEFV GENE; MUTATIONAL ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TNFRSF1A GENE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOTE; ISRAELI; JEW; POPULATION GENETICS; SCORING SYSTEM; SYSTEMIC DISEASE; ETHNOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; INFANT; NUCLEOTIDE SEQUENCE; STATISTICS;

CASPASE RECRUITMENT DOMAIN PROTEIN 15; PYRIN; TUMOR NECROSIS FACTOR RECEPTOR 1; CYTOSKELETON PROTEIN; MARENOSTRIN; NOD2 PROTEIN, HUMAN; TNFRSF1A PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARABS; BEHCET SYNDROME; CHILD; CHILD, PRESCHOOL; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; INFANT; ISRAEL; JEWS; MALE; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, GENETIC; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 80855165330     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. KAKLAMANI VG, VAIOPOULOS G, KAKLAMANiS PG: Behçet's disease. Semin Arthritis Rheum 1998; 27: 197-217.
2. YAZICI H, FRESKO I, YURDAKUL S: Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007; 3 :148-55. (Pubitemid 46416263)
3. O'DUFFY JD: Behçet's disease. Curr Opin Rheumatol 1994; 6: 39-43.
4. INTERNATIONAL STUDY GROUP FOR Behçet's DISEASE: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
5. MENDES D, CORREIA M, BARBEDO M et al: Behçet's disease-a contemporary review. J Autoimmun 2009; 32: 178-88.
6. VERITY DH, MARR JE, OHNO S, WALLACE GR, STANSFORD MR: Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999;54:213-20. (Pubitemid 29443840)
7. KRAUSE I, MOLAD Y, WEINBERGER A: Association of HLA-B5 with clinical expression and severity of Behçet's disease in Israel. J Clin Rheumatol 1999; 5: 137-40. (Pubitemid 29264699)
8. AYESH S, ABU-RMAILEH H, NASSAR S et al.: Molecular analysis of MEFV gene mutations among Palestinian patients with Behçet's disease. Scand J Rheumatol 2008; 37: 370-4.
9. ATAGUNDUZ P, ERGUN T, DIRESKENELI H: MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 2003; 21: S35-7. (Pubitemid 37193095)
10. TOUITOU I, MAGNE X, MOLINARI N et al: MEFV mutations in Behçet's disease. Human Mutation 2000; 16:271-2.
11. IMIRZALIOGLU N, DURSUN A, TASTAN B, SOYSAL Y, YAKICIER MC: MEFV gene is a probable susceptibility gene for Behçet's disease. Scand J Rheumatol 2005; 34: 56-8. (Pubitemid 40445060)
12. RABINOVICH E, SHINAR Y, LEIBA M, EHRENFELD M, LANGEVITZ P, LIVNEH A: Common FMF alleles may predispose to development of Behçet's disease with increased risk for venous thrombosis. Scand J Rheumatol 2007; 36: 48-52. (Pubitemid 46572912)
13. DURSUN A, DURAKBASI-DURSUN HG, ZAMANI AG, GÜLBAHAR ZG, DURSUN R, YAKICIER C: Genetic analysis of MEFV gene pyrin domain in patients with Behçet's disease. Mediators Inftamm 2006; 41: 783.
14. ESPINOSA G, AROSTEGUI Jl, PLAZA S et al.: Behçet's disease and hereditary periodic fever syndromes: casual association or causal relationship? Clin Exp Rheumatol 2005; 23: S64-6.
15. AHMAD T, ZHANG L, GOGUS F et al.: CARD15 polymorphisms in Behçet's disease. Scand J Rheumatol 2005; 34: 233-7.
16. UYAR FA, SARUHAN-DIRESKENELI G, GÜL A: Common Crohn's disease-predisposing variants of the CARD15/NOD2 gene are not associated with Behçet's disease in Turkey. Clin Exp Rheumatol 2004; 22: S50-2.
17. CATTAN D: MEFV mutation carriers and diseases other than familial Mediterranean fever: proved and non-proved associations; putative biological advantage. Curr Drug Targets Inftamm Allergy 2005; 4: 105-12. (Pubitemid 40584860)
18. GERSHONI-BARUCH R, KEPTEN I, SH1NAWI M, BRIK R: Direct detection of common mutations in the familial Mediterranean fever gene (MEFV) using naturally occurring and primer mediated restriction fragment analysis. Mutation in brief no. 257. Online. Hum Mutat 1999; 14: 91.
19. GERSHONI-BARUCH R, SHINAWI M, LEAH K, BADARNAH K, BRIK R: Familial Mediterranean fever: prevalence, penetrance and genetic drift. Eur J Hum Genet 2001; 9: 634-7. (Pubitemid 32776380)
20. KRAUSE I, MADER R, SULKES J et al.: Behçet's disease in Israel: the influence of ethnic origin on disease expression and severity. J Rheumatol 2001; 28: 1033-6. (Pubitemid 32422584)
21. BEN-CHETRIT E, COHEN R, CHAJEK-SHAUL T: Familial mediterranean fever and Behçet's disease-are they associated? J Rheumatol 2002; 29: 530-4. (Pubitemid 34202823)